Al's Comment:

 Amazing results.  For recurrent gbm, 1 year survival of 92% compared to 15% historical controls.

---

Posted on: 11/19/2019

RESULTS OF PHASE II CLINICAL TRIAL OF ONCOLYTIC HERPES VIRUS G47Δ IN PATIENTS WITH GLIOBLASTOMA

 

---

Click HERE to return to brain tumor news headlines.